These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2270368)
1. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention. Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention. Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone. Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444 [TBL] [Abstract][Full Text] [Related]
4. Chemical medullectomy does not prevent sodium retention in nephrotic rats. Keeler R Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491 [TBL] [Abstract][Full Text] [Related]
5. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
6. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome. Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683 [TBL] [Abstract][Full Text] [Related]
7. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats. Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608 [TBL] [Abstract][Full Text] [Related]
8. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats. Radin MJ; Wilke WL; Fettman MJ Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253 [TBL] [Abstract][Full Text] [Related]
9. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats. Bistrup C; Thiesson HC; Jensen BL; Skøtt O Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676 [TBL] [Abstract][Full Text] [Related]
10. Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis. Pedraza-Chaverri J; Cruz C; Sandoval AA; Tapia E; Peña JC Ren Fail; 1992; 14(2):155-9. PubMed ID: 1636021 [TBL] [Abstract][Full Text] [Related]
11. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome. Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Brown EA; Markandu ND; Sagnella GA; Jones BE; MacGregor GA Nephron; 1984; 37(1):43-8. PubMed ID: 6371561 [TBL] [Abstract][Full Text] [Related]
13. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin. Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302 [TBL] [Abstract][Full Text] [Related]
15. Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside. Sagae Y; Matsumoto Y; Unno K J Pharmacobiodyn; 1983 Jul; 6(7):475-80. PubMed ID: 6358456 [TBL] [Abstract][Full Text] [Related]
16. Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spontaneously hypertensive rats. Chiu PJ; Brown AD Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):419-33. PubMed ID: 6454943 [TBL] [Abstract][Full Text] [Related]
17. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy. Trachtman H; Del Pizzo R; Valderrama E; Gauthier B Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Säynävälammi P; Pörsti I Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510 [TBL] [Abstract][Full Text] [Related]
19. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats. Trachtman H; Zavilowitz B; Bennett B; Goldsmith DI Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001 [TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system in aminoglycoside-induced acute renal failure. Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]